BUROSUMAB 2
TED (EU)
Detská fakultná nemocnica Košice
Slovakia
€618,314
8 Dec 2026
Description
Predmetom zákazky je dodávka lieku: burosumab 20mg injekčný roztok a burosumab 30 mg injekčný roztok s účinnou látkou burosumab, známy ako Crysvita (ďalej iba „produkt“), pre detských pacientov s X-viazanou formou hypofosfatemickej rachitídy pri splnení všet-kých nižšie vymenovaných kritérií: 1) s dokumentovanou vysokou sérovou koncentráciou FGF-23 2) s geneticky potvrdenou mutáciou v PHEX géne 3) perzistencii nízkej hypofosfatémie napriek dlhodobej substitúcii maximálnymi tolerovanými dávkami fosfátového roztoku a aktívnej formy vitamínu D 4) pri progresii kostných deformít napriek podávaniu maximálnych tolerovaných dávok štandardnej lieč-by (fosfáty a vitamín D)
The record
As published. The notice text stays with the publisher.
Buyer
Detská fakultná nemocnica Košice
Country
Slovakia
Regions (NUTS)
Category
Medical equipments, pharmaceuticals and personal care products · Medical equipment and pharmaceuticals33632000
Contract value
€618,314
Deadline
8 Dec 2026
Published
9 Nov 2026
Languages
sk
Source
TED (EU) · 778347-2026
How to bid
Procedure
Open - anyone may submit a tender
Submit your tender at
http://evo.isepvo.sk
Submission language
SLK, CES
Electronic submission
Required
Tender documents
Freely available
Award criteria
NAJNIŽŠIA CENA ZA PREDMET ZÁKAZKY
How the award is decided
Celková cena predmetu zákazky v EUR s DPH, v prípade, že uchádzač nie je platcom DPH celková cena predmetu zákazky.
Tenders opened
2026-12-08+01:00
Contract terms
Type of contract
Supplies
Place of performance
SK042
Duration
24 months
Your tender must stay valid for
3 months
Framework agreement
Yes, without reopening competition
Dynamic purchasing system
No
Variant tenders
Not allowed
EU funded
No
Legal basis
32014L0024
Contact the buyer
obstaravanie@dfnkosice.sk
Phone
+421552352909
Address
Trieda SNP, 04011, Košice - mestská časť Západ
Can your company bid for this?
Paste a website. We read what the company does and score it against this tender. No account.
Open tenders like this one
Ranked by what the notices are about, not by matching words in the title.
Selektivní imunosupresiva - Ravulizumab III.
CzechiaInstitut klinické a experimentální medicíny
Closes: 11 Nov 2026
Léčivé přípravky s obsahem ruxolitinibu - Sdružený nákup 2026
CzechiaFakultní nemocnice Hradec Králové
Closes: 12 Nov 2026
Notice data is reused from official sources: Tenders Electronic Daily (TED), published by the Publications Office of the European Union under Commission Decision 2011/833/EU; oeffentlichevergabe.de and TenderNed, published under CC0; BOAMP, published under the Licence Ouverte 2.0; Find a Tender, published under the Open Government Licence v3; and e-Zamówienia, the Plataforma de Contratación del Sector Público and the Piattaforma di Pubblicità a Valore Legale published by ANAC, Doffin and Hilma, published by their national authorities. Each notice links to the original, which is the version that governs.
See only the ones that fit your company
Notices like this one open every week. A profile puts the ones your company can win in front of you, scored, with a line explaining each match.
Start free